Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Frontiers in Oncology
|
May 16, 2022
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
Ryan Miller, Andrew Song, Ayesha Ali, et al.
Cancer Discovery
|
December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms
Jessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Discovery
|
March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms
Jessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
Dolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 20, 2023
IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system
Maryamsadat Seyedsadr, Yan Wang, Manal Elzoheiry, et al.
Science Signaling
|
June 11, 2024
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress
Vivian Chua, Melisa Lopez-Anton, Mizue Terai, et al.
Research Square
|
April 17, 2023
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy
Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, et al.
Breast Cancer Research and Treatment
|
June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome
Cody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Cancer Research
|
July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells
Signe Caksa, Timothy J Purwin, Dan A Erkes, et al.
Breast Cancer Research and Treatment
|
July 17, 2023
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy
Lubna N Chaudhary, Julie M Jorns, Yunguang Sun, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Frontiers in Oncology
|
May 16, 2022
Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
Ryan Miller, Andrew Song, Ayesha Ali, et al.
Cancer Discovery
|
December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms
Jessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Cancer Discovery
|
March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms
Jessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
Dolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 20, 2023
IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system
Maryamsadat Seyedsadr, Yan Wang, Manal Elzoheiry, et al.
Science Signaling
|
June 11, 2024
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress
Vivian Chua, Melisa Lopez-Anton, Mizue Terai, et al.
Research Square
|
April 17, 2023
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy
Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, et al.
Breast Cancer Research and Treatment
|
June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome
Cody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Cancer Research
|
July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells
Signe Caksa, Timothy J Purwin, Dan A Erkes, et al.
Breast Cancer Research and Treatment
|
July 17, 2023
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy
Lubna N Chaudhary, Julie M Jorns, Yunguang Sun, et al.
Page
of 15